OTC Markets OTCPK - Delayed Quote USD

PolyNovo Limited (CALZF)

1.4200 -0.0500 (-3.40%)
At close: May 24 at 10:09 AM EDT
Advanced Chart
Loading Chart for CALZF
DELL
  • Previous Close 1.4700
  • Open 1.4200
  • Bid --
  • Ask --
  • Day's Range 1.4200 - 1.4200
  • 52 Week Range 0.4000 - 1.5360
  • Volume 2,000
  • Avg. Volume 491
  • Market Cap (intraday) 980.131M
  • Beta (5Y Monthly) 1.61
  • PE Ratio (TTM) ∞
  • EPS (TTM) 0.0000
  • Earnings Date Aug 21, 2024 - Aug 26, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell Implant to host pancreatic islet cells in the skin; NovoSorb MTX for the treatment of varying complex wounds; and plastics and reconstructive device product. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

www.polynovo.com

237

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

More about PolyNovo Limited

Recent News: CALZF

View More
View More

Performance Overview: CALZF

Trailing total returns as of 5/28/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CALZF
77.50%
S&P/ASX 200 [XJO]
2.41%

1-Year Return

CALZF
42.00%
S&P/ASX 200 [XJO]
8.65%

3-Year Return

CALZF
28.28%
S&P/ASX 200 [XJO]
8.28%

5-Year Return

CALZF
47.41%
S&P/ASX 200 [XJO]
15.03%

Compare To: CALZF

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

CALZF
PolyNovo Limited
1.4200
-3.40%
Mkt Cap 980.131M
Industry Medical Devices
CLLKF
BICO Group AB (publ)
4.1100
+1.38%
Mkt Cap 291.036M
Industry Medical Devices
NARI
Inari Medical, Inc.
49.95
+5.29%
Mkt Cap 2.904B
Industry Medical Devices

Statistics: CALZF

View More

Valuation Measures

Annual
As of 5/24/2024

  • Market Cap

    947.68M

  • Enterprise Value

    927.68M

  • Trailing P/E

    858.19

  • Forward P/E

    140.85

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    18.02

  • Price/Book (mrq)

    21.45

  • Enterprise Value/Revenue

    16.93

  • Enterprise Value/EBITDA

    625.90

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.91%

  • Return on Assets (ttm)

    -1.10%

  • Return on Equity (ttm)

    2.42%

  • Revenue (ttm)

    83.47M

  • Net Income Avi to Common (ttm)

    1.59M

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    45.63M

  • Total Debt/Equity (mrq)

    22.20%

  • Levered Free Cash Flow (ttm)

    -6.45M

View More

Company Insights: CALZF

People Also Watch

PHGUF Pharming Group N.V.
0.9539
+5.38%
 
PTCHF PureTech Health plc
2.8600
+2.14%
 
MEOBF Mesoblast Limited
0.6750
-14.56%
 
CVALF Covalon Technologies Ltd.
0.7724
-4.05%
 
CLCS Cell Source, Inc.
0.0008
+300.00%
 
RVXCF Resverlogix Corp.
0.0348
-24.35%
 
SLNCF Silence Therapeutics plc
7.00
0.00%
 
CLVLF Clinuvel Pharmaceuticals Limited
10.00
+2.41%
 
CLVLY Clinuvel Pharmaceuticals Limited
10.34
+0.39%
 
BIOAF Bioasis Technologies Inc.
0.0040
-33.33%
 
IPDQF ImpediMed Limited
0.0551
-38.78%
 
MCUJF Medicure Inc.
0.8000
+13.85%
 
NGENF NervGen Pharma Corp.
1.5085
-0.10%
 
NUMD Nu-Med Plus, Inc.
0.0500
+24.69%
 
EMMA Emmaus Life Sciences, Inc.
0.0921
-4.11%
 
MRZM Marizyme, Inc.
0.0930
+74.48%